{"id":49679,"date":"2025-06-27T16:11:38","date_gmt":"2025-06-27T14:11:38","guid":{"rendered":"https:\/\/www.bricbordeaux.com\/2025\/06\/ahmad-sharanek-appointed-inserm-research-associate\/"},"modified":"2025-07-01T11:08:03","modified_gmt":"2025-07-01T09:08:03","slug":"ahmad-sharanek-appointed-inserm-research-associate","status":"publish","type":"post","link":"https:\/\/www.bricbordeaux.com\/en\/2025\/06\/ahmad-sharanek-appointed-inserm-research-associate\/","title":{"rendered":"Ahmad Sharanek appointed INSERM Research Associate"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/www.bricbordeaux.com\/people\/ahmad-sharanek-2\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ahmad Sharanek<\/a> appointed Charg\u00e9 de Recherche INSERM: a journey of perseverance and continuous improvement<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\"><em>BRIC is pleased to congratulate Ahmad Sharanek (also spelled Charanek), researcher in <a href=\"https:\/\/www.bricbordeaux.com\/en\/bric-team\/equipe-1-laboratoire-de-biologie-tumorale-et-vasculaire\/\" target=\"_blank\" rel=\"noreferrer noopener\">Team 1<\/a>, on his recent appointment as a &#8220;Charg\u00e9 de Recherche Classe Normale&#8221; (CRCN) at <a href=\"https:\/\/www.inserm.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Inserm<\/a>. A well-deserved recognition, following one of the most selective national competitions, the result of many years of hard work, reflection, and of course, tenacity.<\/em><\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>An international journey, from fundamental biology to oncology<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Originally from Lebanon, Ahmad Sharanek first studied biology before enrolling in a Master\u2019s program in his home country. Fascinated by research, he moved to Rennes in 2011 to complete a PhD on drug-induced liver toxicity. In 2018, he continued his international path with a postdoctoral position in Montreal, where he specialized in tumor cell metabolism, particularly in glioblastoma, a particularly aggressive form of brain cancer<\/p>\n\n<p class=\"wp-block-paragraph\">In 2022, he joined Team 1 at BRIC \u2014 led by Lucie Brisson and Thomas Mathivet \u2014 where he is developing two research axes centered on metabolism: one in brain tumors and the other in liver diseases.<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Autonomous research supported by major funding<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Supported successively by the Fondation de France, the European Commission\u2019s Marie Sk\u0142odowska-Curie Actions, and then the ANR JCJC program, Ahmad Sharanek has successfully secured prestigious funding at every stage of his career\u2014covering both his salary and his research needs (purchase of reagents, equipment, recruitment of students, etc.).<\/p>\n\n<p class=\"wp-block-paragraph\">This funding has enabled him to independently develop innovative research projects and strengthen interdisciplinary collaborations, particularly with chemists, bioinformaticians, and clinicians.<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>A highly selective national competition, where every word matters<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Succeeding in the Inserm CRCN competition is no small feat. Ahmad Sharanek explains: \u201cThe path is long and the positions are few, but every application helped refine my project. Even the rejections were constructive.\u201d He applied three consecutive years, progressing each time, until finally earning a double ranking (in two different thematic sections) with a 4th place position this year.<\/p>\n\n<p class=\"wp-block-paragraph\">The young researcher credits this success not only to persistence, but also to the critical support of colleagues at BRIC who helped him revise and strengthen his scientific dossier. <\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Becoming tenured: recognition, responsibility, and new perspectives<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">\u201cBeing appointed Charg\u00e9 de Recherche is recognition of my journey, my scientific autonomy and the relevance of my projects to Inserm\u2019s priorities. It\u2019s also a new beginning, as this status provides essential stability to build a long-term scientific trajectory.\u201d<\/p>\n\n<p class=\"wp-block-paragraph\">&#8220;This position allows me to plan my research over 5 to 10 years without the constant anxiety of contract renewals. It also makes it easier to secure funding by enhancing the credibility of my projects and allows me to recruit new people to work with. Finally, it\u2019s a strong signal of trust\u2014a real encouragement to continue and expand my work.&#8221; \u2014 Ahmad adds.<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>To teach, to mentor, and to keep innovating?<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Already deeply engaged in supervising Master\u2019s and PhD students, Ahmad is open to contributing to teaching, but remains primarily committed to his research mission. His ambition is to deepen the lines of investigation he has launched and to continue advancing translational science that can ultimately benefit patients.<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\">Congratulations again, Ahmad!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ahmad Sharanek appointed Charg\u00e9 de Recherche INSERM: a journey of perseverance and continuous improvement BRIC is pleased to congratulate Ahmad Sharanek (also spelled Charanek), researcher in Team 1, on his recent appointment as a &#8220;Charg\u00e9 de Recherche Classe Normale&#8221; (CRCN) at Inserm. A well-deserved recognition,&#8230;<\/p>\n","protected":false},"author":3,"featured_media":49675,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[111,8],"tags":[],"class_list":["post-49679","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/posts\/49679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/comments?post=49679"}],"version-history":[{"count":4,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/posts\/49679\/revisions"}],"predecessor-version":[{"id":49684,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/posts\/49679\/revisions\/49684"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/media\/49675"}],"wp:attachment":[{"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/media?parent=49679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/categories?post=49679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bricbordeaux.com\/en\/wp-json\/wp\/v2\/tags?post=49679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}